Evidence map›Paper›PMID 37953446›Full record

ArticleBrain tumor research and treatment2023

A Case Series of DuraMatrix-Onlay

Mahlet Mekonnen, Gabrielle Hovis, Natalie Mahgerefteh, Anubhav Chandla, Yelena Malkhasyan, Ashley B Zhang, Isaac Yang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain tumor research and treatment, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mahlet MekonnenDepartment of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0009-0004-5342-7793
Gabrielle HovisDepartment of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0002-1150-2458
Natalie MahgereftehDepartment of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0002-1294-9112
Anubhav ChandlaDepartment of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0009-0001-3999-8811
Yelena MalkhasyanDepartment of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0009-0008-2589-2435
Ashley B ZhangDepartment of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0002-1362-6489
Isaac YangDepartment of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0002-5176-5615
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuraMatrix-Onlay

methodsThis is a retrospective case series of 33 patients who underwent a duraplasty procedure at a single academic hospital in Los Angeles, CA, USA between May 2016 and March 2017. The primary outcome was the incidence rate of cerebrospinal fluid (CSF) leak. Secondary outcomes included rates of patient infection, dural substitute complication, and removal.

resultsThirty-three patients underwent a duraplasty procedure using the DuraMatrix-Onlay

conclusionDuraMatrix-Onlay

Indexed as

Brain neoplasmsDura materGraftNeurosurgeryOnlay

Identifiers

PMID37953446
PMCPMC10641318
OpenAlexW4388400882

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.